NCT07588776

Brief Summary

The current study is a randomized controlled trial comparing the effectiveness of myofascial release therapy used alone versus myofascial release combined with clinical taping for individuals with heel spurs. The trial aims to evaluate improvements in pain, foot function, and overall disability. Interventions will be delivered twice weekly for a specified duration. The primary outcome is pain reduction, while secondary outcomes include improved foot function and reduced disability. The hypothesis is that the combination of myofascial release and taping will result in significantly greater clinical improvements compared to myofascial release alone.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
38

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 6, 2026

Completed
23 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 29, 2026

Completed
7 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 6, 2026

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

May 9, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 15, 2026

Completed
Last Updated

May 18, 2026

Status Verified

May 1, 2026

Enrollment Period

23 days

First QC Date

May 9, 2026

Last Update Submit

May 14, 2026

Conditions

Keywords

Myofascial RealeaseKinesiology TapingPhysical TherapyManual TherapyFoot Pain

Outcome Measures

Primary Outcomes (1)

  • Pain Intensity

    Pain intensity will be measured using the Visual Analog Scale (VAS), where participants mark their pain level on a 100mm line ranging from "no pain" (0) to "worst imaginable pain" (100). Higher scores indicate greater pain intensity.

    Baseline and 4 weeks post-intervention.

Secondary Outcomes (2)

  • Foot Function

    Baseline and 4 weeks

  • Disability level

    Baseline and 4 weeks

Study Arms (2)

Myofascial Release with Clinical Taping

EXPERIMENTAL

Participants in this arm will receive a combination of myofascial release therapy and clinical taping. Myofascial release will be applied to the plantar fascia and the posterior chain muscles. Following the manual therapy, clinical taping (such as Kinesiology tape or rigid tape, depending on your specific protocol) will be applied to the affected foot to provide mechanical support and proprioceptive feedback. Sessions will be conducted twice weekly.

Other: Myofascial Release with Clinical Taping

Myofascial Release Alone

ACTIVE COMPARATOR

Participants in this arm will receive the standardized myofascial release protocol only. The therapy will target the plantar fascia and surrounding soft tissues to reduce restrictions and pain. No clinical taping or additional manual interventions will be applied. Sessions will be conducted twice weekly to match the frequency of the experimental group

Other: Myofascial Release Alone

Interventions

Participants will receive a 45-minute intervention session. The integrated components consist of manual myofascial release techniques followed by the application of clinical taping to the affected foot.

Also known as: Group A Intervention
Myofascial Release with Clinical Taping

Participants will receive the same 30 minutes of specialized myofascial release (MFR) manual therapy targeting the plantar fascia and calf musculature. No clinical taping will be applied. Sessions will be conducted twice weekly to ensure a consistent treatment frequency with the experimental group.

Also known as: Group B Intervention
Myofascial Release Alone

Eligibility Criteria

Age30 Years - 40 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Age 30-40 years
  • Both males and females
  • Clinically or radiographically confirmed heel spur
  • Pain intensity ≥ 3 on Visual Analog Scale
  • Symptom duration ≥ 4 weeks
  • Able to attend treatment sessions 3 times per week
  • Able to provide informed consent

You may not qualify if:

  • Previous foot or heel surgery
  • Current physiotherapy treatment for heel pain
  • Neurological disorders (e.g., neuropathy, radiculopathy)
  • Systemic inflammatory diseases (e.g., rheumatoid arthritis, gout)
  • Severe musculoskeletal deformities of the foot
  • Open wounds, skin infection, or allergy to tape
  • Corticosteroid injection in the last 3 months
  • Pregnancy
  • Any medical condition preventing safe participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Green International University

Lahore, Punjab Province, Pakistan

Location

MeSH Terms

Conditions

Heel Spur

Interventions

Myofascial Release Therapy

Condition Hierarchy (Ancestors)

ExostosesHyperostosisBone DiseasesMusculoskeletal DiseasesFoot Diseases

Intervention Hierarchy (Ancestors)

MassageTherapy, Soft TissueMusculoskeletal ManipulationsComplementary TherapiesTherapeuticsPhysical Therapy ModalitiesRehabilitation

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Masking Details
This study uses single masking in which the outcome assessor is blinded to group allocation. Participants will be assigned to either the Myofascial Release with taping group or the Myofascial Release only group by an independent researcher who is not involved in assessment. The assessor responsible for recording baseline and post intervention outcomes (VAS and FFI scores) will not be informed of the participants' intervention group. To maintain blinding, participants will be instructed not to disclose their group assignment during assessments.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This study uses a randomized, parallel-group design in which participants diagnosed with heel spur are assigned into one of two intervention arms. Participants will be randomly allocated to either: (1) Myofascial Release combined with taping, or (2) Myofascial Release alone. Both group will receive the same standardized Myofascial Release protocol, while only the experimental group will receive additional taping after each therapy session. The outcome assessor will be blinded to group assignment to minimize measurement bias. The interventions will be delivered over a 4 weeks period, and outcomes will be compared between groups to evaluate the added effect of taping when used alongside Myofascial Release..
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 9, 2026

First Posted

May 15, 2026

Study Start

April 6, 2026

Primary Completion

April 29, 2026

Study Completion

May 6, 2026

Last Updated

May 18, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will share

Only IPD used in the results publication will be shared.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
It will be available after the completion of the study.
Access Criteria
Through the corresponding author.

Locations